Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromuscular Changes In Small For Gestational Age (SGA) Children During Somatropin Therapy - A Prospective Randomized, Controlled, Open-Label Multicenter Trial

NCT00625872 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00625872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00625872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromuscular Changes In Small For Gestational Age (SGA) Children During Somatropin Therapy - A Prospective Randomized, Controlled, Open-Label Multicenter Trial
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2008
Completion date
March 31, 2011
Enrollment
23 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone therapy, infant, small for gestational age